Prostate Cancer - Results from #26000

Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): A new risk factor for prostate cancer - Abstract April 30, 2012

Periprostatic lymph node metastasis in prostate cancer and its clinical significance - Abstract April 30, 2012

Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer - Abstract April 27, 2012

Blood cells and their use in active immunotherapy of prostate cancer - Abstract April 27, 2012

Understanding fragmentation of prostate cancer survivorship care: Implications for cost and quality - Abstract April 27, 2012

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: Biochemical outcomes using third generation-based technology - Abstract April 27, 2012

Role of denosumab in prostate cancer - Abstract April 27, 2012

Abiraterone acetate: A guide to its use in metastatic castration-resistant prostate cancer - Abstract April 27, 2012

Targeting prostate cancer stem cells for cancer therapy - Abstract April 27, 2012

An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer - Abstract April 27, 2012

Smokers: At risk for prostate cancer but unlikely to screen - Abstract April 27, 2012

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer - Abstract April 26, 2012

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective - Abstract April 26, 2012

Intrusion, avoidance, and daily negative affect among couples coping with prostate cancer: A dyadic investigation - Abstract April 26, 2012

Genome-wide two-locus epistasis scans in prostate cancer using two European populations - Abstract April 26, 2012

Computer-aided quantitative bone scan assessment of prostate cancer treatment response - Abstract April 25, 2012

In Vivo (31) P MR spectroscopic imaging of the human prostate at 7 T: Safety and feasibility - Abstract April 25, 2012

Muscle function, physical performance and body composition changes in men with prostate cancer undergoing androgen deprivation therapy - Abstract April 25, 2012

Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue - Abstract April 25, 2012

Dose-escalated simultaneous integrated-boost treatment of prostate cancer patients via helical tomotherapy - Abstract April 25, 2012

Page 1301 of 1437